v3.25.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Revenue $ 75,395 $ 69,779 $ 40,698
Total cost of sales 101,085 142,469 100,983
Gross loss (25,690) (72,690) (60,285)
Operating expenses:      
Research and development 231,669 262,217 185,283
Sales and marketing 45,488 53,097 38,672
General and administrative 115,771 159,815 158,162
Impairment of goodwill and intangible assets 6,647 15,489 0
Restructuring costs 9,772 0 0
Total operating expenses 409,347 490,618 382,117
Loss from operations (435,037) (563,308) (442,402)
Change in fair value of warrant liabilities 1,069 1,936 9,222
Interest expense (27,032) (11,048) (11,095)
Interest income 10,418 13,109 5,697
Gain on extinguishment of debt 148,660 0 0
Net loss per share: 1,474 0 0
Changes in fair value of derivative liability 31,729 0 0
Losses and impairments related to investments and certain other assets, and other income (expense) (5,164) (10,262) (6,689)
Total other income (expense), net 161,154 (6,265) (2,865)
Loss before provision for income taxes (273,883) (569,573) (445,267)
Provision for income taxes (743) 1,696 672
Net loss $ (273,140) $ (571,269) $ (445,939)
Net loss per share:      
Basic (in dollars per share) $ (8.70) $ (22.02) $ (18.79)
Diluted (in dollars per share) $ (8.70) $ (22.02) $ (18.79)
Shares used in computing net income (loss) per share:      
Weighted average Common shares outstanding- Basic (in shares) 31,404,616 25,939,912 23,734,269
Weighted average Common shares outstanding- Diluted (in shares) 31,404,616 25,939,912 23,734,269
Comprehensive Loss:      
Net loss $ (273,140) $ (571,269) $ (445,939)
Net unrealized gains (losses) on available-for-sale debt securities (297) 4,228 (3,318)
Comprehensive loss (273,437) (567,041) (449,257)
Products      
Revenue 62,608 45,044 18,492
Total cost of sales 86,005 105,236 61,985
Services      
Revenue 12,787 24,735 22,206
Total cost of sales $ 15,080 $ 37,233 $ 38,998

Source